Semax Product Brief

1. Compound Overview

Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH).
It has been studied for its potential role in neuroprotective signaling, cognitive pathways, and brain-derived neurotrophic factor (BDNF) regulation.

Semax has attracted research interest in neurological and cognitive studies involving learning, memory formation, and neuroprotection mechanisms.

2. Mechanism of Interest

Semax is studied for several biological mechanisms:

• Modulation of brain-derived neurotrophic factor (BDNF) signaling
  • Influence on neurotransmitter regulation pathways
  • Potential neuroprotective signaling effects
  • Interaction with dopaminergic and serotonergic pathways
  • Support of neural plasticity signaling networks

3. Research Areas Being Explored

• Cognitive performance and memory research
  • Neuroprotection and brain health studies
  • Learning and memory signaling pathways
  • Neurological recovery models
  • Neurotransmitter regulation research

4. Safety and Regulatory Notes

Semax is not approved by the FDA for general medical treatment in the United States and is commonly distributed as a research compound.

This document is intended for informational and research product description purposes only.